The ankle-brachial index (ABI)

     Determination of the ankle - brachial index (ABI)

Detection of ABI is a rapid, non-invasive way to detect the possibility of peripheral arterial disease (PUP).

Ankle-brachial index (ABI) compares systolic blood pressure (SAS) measured at the wrist and at the ankle.

PAS is a cause of interference and increases the risk of stroke and heart attack. ABI is one of the indicators of subclinical atherosclerosis, and its early detection can help slow or prevent the progression of cardiovascular disease and mortality.

PAS occurs in 10% of people over the age of 55.

     ABI should preferably be identified if the following symptoms or risk factors are present:

•  interference
•  smoking
•  diabetes
•  arterial hypertension
•  hypercholesterolaemia
•  patients after lower extremity revascularization
•  patients after coronary artery bypass grafting and angioplasty
•  patients with GFR <60.0 ml / min / 1.73 m2
•  atherosclerosis of other pelvic arteries
•  recommended for all people over the age of 70
•  CORE> 10%

The determination of ABI is part of the risk assessment and primary prevention measures for cardiovascular disease. ABI <0.9 identifies people with increased morbidity and mortality from future cardiovascular disease.

It is important to consider ABI as an indicator of systemic atherosclerosis, not just as it is associated with leg artery disease.

The assessment of ABIs can identify patients for whom short-term and long-term cardiovascular events can be prevented by adjusting risk factors.

Prices: